مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| ارزیابی فناوری سلامت× | تحلیل هزینه-اثربخشی در ارزیابی فناوری سلامت× | |
|---|---|---|
| حوزه | مدیریت خدمات سلامت | مدیریت خدمات سلامت |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1980 | 1996 |
| پدیدآور≠ | International HTA organizations, National Institutes of Health | Diane Meade Drummond, Michael Gold |
| نوع≠ | Structured assessment methodology | Economic evaluation methodology |
| منبع بنیادین≠ | Goodman, C. S. (2004). HTA 101: Introduction to Health Technology Assessment (Version 1.0). National Library of Medicine, National Institutes of Health. link ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 |
| نامهای دیگر | HTA, Technology Assessment Healthcare | CEA, Cost-Effectiveness Analysis Healthcare |
| مرتبط | 5 | 5 |
| خلاصه≠ | Health Technology Assessment (HTA) is a structured, multidisciplinary approach to evaluating the clinical, economic, and societal effects of healthcare technologies (devices, drugs, procedures, systems). HTA synthesizes evidence from clinical trials, observational studies, and economic analyses to support decision-makers in adoption and reimbursement determinations. | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. |
| ScholarGateمجموعهداده ↗ |
|
|